The goal of using stem cell therapy to treat osteoarthritis is to promote self-healing and improve the function and quality of life of the patient.
A stem cell therapy can help patients with OA symptoms like improving range of motion, reducing inflammation, reducing stiffness, and even postponing or avoiding surgery, allowing them to participate in their favorite activities.
Osteoarthritis arthritis occurs when the cartilage, which acts as a cushion, wears away.
As the cartilage wears away, the bones begin to rub more closely against each other, causing pain, swelling, stiffness, and in later stages of the disease, the formation of bone spurs, and bone on bone contact.
As the swelling, stiffness, and pain worsens you may find yourself limiting your movement, thereby worsening the problem.
Reduced movement can lead to increased muscle wasting and ligament laxity, both of which reduce the strength and stability.
Conventional non-surgical treatments treat the symptoms but not the underlying disease, and they can have serious side effects if used for a long time.
Surgery is the only FDA approved treatment that can provide a long-term cure, but there can be serious surgical complications.
It can take up to a year to fully recover after surgery. After 6 weeks, you should be able to resume normal activities, although the pain and inflammation may take 3 months to 1 year to subside.
The following are some risks associated with the surgical procedure:
Stem cells aid in self-healing of the joint cartilage. Osteoarthritis develops as the immune system gradually deteriorates, cartilage is damaged, bone structure is altered, and chronic synovial inflammation develops.
Mesenchymal stem cells have been found to regulate the immune system, inhibit inflammation, increase blood vessel formation, repair tissue, and stimulate cartilage self-regeneration.
The patient’s stem cells and platelet-rich plasma can be easily harvested. These stem cells are specific to the patient, ensuring that the cells will not be rejected.
The entire procedure is relatively quick, and most patients are up and walking with assistance within 24 hours.
Patients will experience minor discomfort, and most will be able to return to work in 1-2 weeks, depending on the job type. If the patient works a desk job, he or she may be able to return in a few days.
Stem Cells Transplant Institute uses autologous mesenchymal stem cells derived from the patient’s own adipose tissue and bone marrow for the treatment of OA.
Autologous means the stem cells are collected from the recipient so the risk of rejection is virtually eliminated.
Mesenchymal stem cells are a type of adult stem cell that are found in a variety of tissues such as adipose tissue, the lung, bone marrow, and the blood.
Due to stem cell viability, in patients over the age of 65 it may be necessary to use human umbilical cord stem cells.
Our stem cells age with us. It is necessary to be able to collect a sufficient quantity of viable stem cells in order to get a positive response. You and your physician can decide if umbilical cord stem cells are the preferred option for you.
Our clinic focuses on obtaining healthy stem cells exclusively from umbilical cord blood donors. We collect the placenta once the baby is born, with the parent’s informed consent. Additionally, we follow strict ethical guidelines and collect stem cells from reliable and reputable sources.
Our nursing staff administers the stem cells through an intravenous and intra-pulmonary route. For the most effective outcomes, intravenous administration is preferred.
Our clinic is located in Costa Rica, which is one of the most popular medical tourism destinations for stem cell therapy. At the Stem Cells Transplant Institute, we have a skilled team of doctors and medical professionals who collect and administer stem cells to treat autism and other conditions. Every patient receives the most cost-effective and top-notch care from our dedicated team.
Copyright ©2024 Stem Cells Transplant Institute. All rights reserved. Developed by SUWEBCR
